Smith+Nephew received FDA 510(k) clearance to market a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless).
AETOS Stemless addresses the growing demand for anatomic total shoulder replacement with a small operating room footprint allowing for an efficient procedure. It is designed to maximize metaphyseal fixation and stability with an inlay collar, cruciate fins and porous titanium coating to encourage biological fixation.
The AETOS Shoulder System was introduced last year. The new stemless implant expands the AETOS Shoulder System portfolio enabling streamlined convertibility from Stemless to Meta Stem.
“AETOS Stemless represents a significant advancement in shoulder arthroplasty, underscoring our commitment to superior patient outcomes and driving progress in the field of orthopaedic surgery. We are excited to continue unveiling future technologies that will reshape the treatment of shoulder conditions,” said Craig Gaffin, President of Global Orthopaedics for Smith+Nephew. “With AETOS Stemless, we’re now able to further personalize surgery, providing options that help surgeons give patients the best chance for recovery and a return to living their Life Unlimited.”
The AETOS Shoulder System, including AETOS Stemless, is cleared for use in the United States and approved for use in Canada.
Smith+Nephew received FDA 510(k) clearance to market a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless).
AETOS Stemless addresses the growing demand for anatomic total shoulder replacement with a small operating room footprint allowing for an efficient procedure. It is designed to maximize metaphyseal fixation...
Smith+Nephew received FDA 510(k) clearance to market a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless).
AETOS Stemless addresses the growing demand for anatomic total shoulder replacement with a small operating room footprint allowing for an efficient procedure. It is designed to maximize metaphyseal fixation and stability with an inlay collar, cruciate fins and porous titanium coating to encourage biological fixation.
The AETOS Shoulder System was introduced last year. The new stemless implant expands the AETOS Shoulder System portfolio enabling streamlined convertibility from Stemless to Meta Stem.
“AETOS Stemless represents a significant advancement in shoulder arthroplasty, underscoring our commitment to superior patient outcomes and driving progress in the field of orthopaedic surgery. We are excited to continue unveiling future technologies that will reshape the treatment of shoulder conditions,” said Craig Gaffin, President of Global Orthopaedics for Smith+Nephew. “With AETOS Stemless, we’re now able to further personalize surgery, providing options that help surgeons give patients the best chance for recovery and a return to living their Life Unlimited.”
The AETOS Shoulder System, including AETOS Stemless, is cleared for use in the United States and approved for use in Canada.
Copy to clipboard 
